Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu… - Cancer Immunology …, 2013 - Springer
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …
被引用次数：121 相关文章
[HTML] nih.gov

[HTML][HTML] Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu… - Cancer Immunology …, 2013 - ncbi.nlm.nih.gov
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu… - Cancer Immunology …, 2012 - europepmc.org
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …
[PDF] researchgate.net

[PDF][PDF] Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu, NP Restifo… - researchgate.net
The genetic modification of CD8? T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu… - Cancer Immunology …, 2013 - infona.pl
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu… - Cancer Immunology …, 2013 - search.proquest.com
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang… - Cancer Immunology …, 2013 - pure.johnshopkins.edu
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails

S Yang, Y Ji, L Gattinoni, L Zhang… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

S Yang, Y Ji, L Gattinoni, L Zhang… - Cancer Immunology …, 2013 - search.ebscohost.com
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

S Yang, Y Ji, L Gattinoni, L Zhang… - Cancer Immunology …, 2013 - search.ebscohost.com
The genetic modification of CD8+ T cells using anti-tumor T-cell receptors (TCR) or chimeric
antigen receptors is a promising approach for the adoptive cell therapy of patients with …